RDF19 Poster Detail
|Counting the cost of research: A penny earned is a penny saved|
Clinical research can generate substantial cost savings for the NHS. Despite these savings the tendency is to only focus on Excess Treatment Costs to support research. Recognising and reporting savings can be used to offset some of these Excess Treatment Costs.
Moreover, researchers often report that they find the process for applying for Excess Treatment costs too complicated.
In order to simplify the process of applying for research approvals, NHS England has asked the 15 NIHR LCRNs to manage Excess Treatment Costs on behalf of CCG’s. LCRNs will manage a pre-identified local annual funding pot provided by CCG.
How then is the Trust recognising and reporting its Excess Treatment Savings, to inform their local CCG what their pre-identified local annual funding pot should look like?
At University Hospitals Plymouth NHS Trust, the research department has spent many years developing a process which allows for monthly calculations of Excess Treatment Savings.
The process involved taking monthly pharmacy dispensing reports, separating each dispensing into the specific trial and working out what each individual’s savings were.
The resulting process is collaborative across the trust with the recognition of the importance of recording excess treatment savings.
Consequently New Devon CCG has concluded that the process developed absolutely provided clarity, and was really useful to commissioners and the provider teams involved in the high cost drug work streams. The data was also useful to help us (CCG) understand trends in drug spend.
Plymouth has therefore developed a process which identifies its Excess Treatment Savings which is reported to the CCG so that they can start to identify their local annual funding pot.
Due to the success of the project, there are plans to roll out similar reporting across the South West
|University Hospitals Plymouth NHS Trust|